The present invention is based on the elucidation of the global changes in gene expression and the identification of toxicity markers in tissues or cells exposed to a known toxin. The genes may be used as toxicity markers in drug screening and toxicity assays. The invention includes a database of genes characterized by toxin-induced differential expression that is designed for use with microarrays and other solid-phase probes.

 
Web www.patentalert.com

< Oncogene, recombinant protein derived therefrom, and uses thereof

> Alternatively spliced nucleic acid molecules

~ 00484